Penn State Health hospitals receive high marks in Leapfrog’s hospital safety grades

Michael Kupferman, MD, MBA Chief Executive Officer, Penn State Health - Penn State Health
Michael Kupferman, MD, MBA Chief Executive Officer, Penn State Health - Penn State Health
0Comments

Penn State Health has been recognized for its strong performance in patient safety, with all five of its hospitals receiving high marks in the latest Hospital Safety Grades from the Leapfrog Group. The ratings, released on November 13, 2025, show continued commitment to safety across the health system.

Dr. Michael Kupferman, chief executive officer of Penn State Health, said, “Our commitment to safety is embedded in every aspect of care we provide. These grades reflect the dedication of our entire team to creating a secure, healing environment for every patient, every day.”

For the second consecutive reporting period, Penn State Health Hampden Medical Center, Lancaster Medical Center and Milton S. Hershey Medical Center each earned an ‘A’ grade—the highest rating available from Leapfrog. Holy Spirit and St. Joseph medical centers received ‘B’ grades again, showing consistent performance throughout the organization.

The Leapfrog Group is a national nonprofit organization that reviews nearly 3,000 general acute-care hospitals twice per year. Its evaluations are based on more than 30 publicly available measures related to how well hospitals prevent errors and harm to patients.

Leah Binder, president and chief executive officer of the Leapfrog Group stated: “Achieving an ‘A’ Hospital Safety Grade reflects enormous dedication to patient safety. I extend my congratulations to Penn State Health, its leadership, clinicians, staff and volunteers for creating a culture where patients come first.”

The full survey results can be accessed at HospitalSafetyGrade.org.



Related

David H. Mccormick, U.S. Senator

Senator Dave McCormick comments on Middle East diplomacy and Pennsylvania manufacturing

Senator Dave McCormick posted on April 10 about ongoing Middle East negotiations involving Israel and Lebanon, praised job creation by Victaulic in Pennsylvania, and commented on U.S. strategy toward Iran.

David H. Mccormick, U.S. Senator

Senator Dave McCormick addresses fentanyl crisis and U.S.-Iran policy in recent posts

Senator Dave McCormick published posts between April 7–9 discussing his meetings with law enforcement about fentanyl’s impact on families in Pennsylvania and emphasizing U.S. policy toward Iran’s nuclear program.

David H. Mccormick, U.S. Senator

Senator Dave McCormick highlights Artemis II milestone and bipartisan efforts

Senator Dave McCormick commented on Artemis II’s historic spaceflight record, U.S.-Iran relations regarding nuclear weapons, and praised bipartisan work with Senator John Fetterman in posts dated April 6-7, 2026.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Dauphin News.